Together Pharma Ltd
TGPHF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,316 | -$33,524 | -$13,776 | $7,152 |
| Dep. & Amort. | $23,854 | $6,003 | $5,479 | $4,237 |
| Deferred Tax | $0 | -$847 | $8,172 | -$1,310 |
| Stock-Based Comp. | $0 | $0 | $1,446 | $4,095 |
| Change in WC | -$13,961 | -$2,520 | -$9,539 | -$34,011 |
| Other Non-Cash | $9,254 | $16,308 | -$2,254 | $8,824 |
| Operating Cash Flow | $14,831 | -$13,733 | -$18,644 | -$9,703 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$866 | -$333 | -$1,530 | -$13,752 |
| Net Acquisitions | $0 | $0 | $5 | $118 |
| Inv. Purchases | $0 | $0 | -$27,227 | $0 |
| Inv. Sales/Matur. | $0 | $33,891 | $27,320 | $0 |
| Other Inv. Act. | -$750 | $33,378 | -$27,320 | -$14,144 |
| Investing Cash Flow | -$1,616 | $33,045 | -$28,850 | -$27,896 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$14,220 | -$29,871 | $27,086 | $30,980 |
| Stock Issued | $0 | $11,528 | $22,554 | $46,238 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$700 | $10,728 | $21,754 | $9,245 |
| Financing Cash Flow | -$14,920 | -$19,143 | $48,840 | $40,225 |
| Forex Effect | $1 | $32 | -$9 | -$5 |
| Net Chg. in Cash | -$1,704 | $201 | $1,337 | $2,621 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $5,296 | $5,095 | $3,758 | $1,137 |
| End Cash | $3,592 | $5,296 | $5,095 | $3,758 |
| Free Cash Flow | $13,965 | -$14,066 | -$20,174 | -$23,455 |